Home/Filings/4/0000899243-17-020282
4//SEC Filing

Sham Hing 4

Accession 0000899243-17-020282

CIK 0001629137other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 9:47 PM ET

Size

5.9 KB

Accession

0000899243-17-020282

Insider Transaction Report

Form 4
Period: 2017-08-11
Sham Hing
See Remarks
Transactions
  • Award

    Restricted Stock Units

    2017-08-11+12,00012,000 total
    Common Stock (12,000 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
  • [F2]The RSUs vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001650158

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 9:47 PM ET
Size
5.9 KB